NCT04883879 is a clinical trial in End Stage Cancer, sponsored by Taipei Medical University.

Who is sponsoring NCT04883879?

NCT04883879 is sponsored by Taipei Medical University.

What condition does NCT04883879 study?

NCT04883879 studies End Stage Cancer.

Is NCT04883879 still recruiting?

NCT04883879 is currently status unknown. Last updated 12 May 2021.

Last reviewed 2021-05-12 · How we verify

NCT04883879

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward

Status unknown Last updated 12 May 2021

What this trial tests

trial in End Stage Cancer in 80 participants. Status unknown.

Timeline

11 December 2019

Primary endpoint
31 August 2021

31 December 2021

Quick facts

Lead sponsor	Taipei Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	80
Start date	11 December 2019
Primary completion	31 August 2021
Estimated completion	31 December 2021
Sites	1 location across Taiwan

Conditions studied

End Stage Cancer — all drugs for End Stage Cancer →

Sponsor

Taipei Medical University

Who can join

20 and older, any sex, with End Stage Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deep-Learning Approach to Predict Survival Outcomes Using Wearable Actigraphy Device Among End-Stage Cancer Patients.
Yang TY, Kuo PY, Huang Y, Lin HW, et al · · 2021 · cited 15× · PMID 34957004 · DOI 10.3389/fpubh.2021.730150

Verify or expand the search:

Other Taipei Medical University trials

Trials by the same sponsor.

NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan · not yet recruiting
NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) · NA · not yet recruiting
NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents · NA · not yet recruiting
NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients · NA · not yet recruiting
NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04883879 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
Last refreshed: 12 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04883879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing